Meitav Dash Investments LTD Lantheus Holdings, Inc. Transaction History

Meitav Dash Investments LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$23.33 - $28.3 $606,580 - $735,800	-26,000 Closed	0 $0
Q1 2019 May 13, 2019	SELL	$14.93 - $25.1 $268,740 - $451,800	-18,000 Reduced 40.91%	26,000 $637,000
Q4 2018 Feb 13, 2019	BUY	$12.68 - $19.01 $35,504 - $53,228	2,800 Added 6.8%	44,000 $656,000
Q3 2018 Nov 14, 2018	BUY	$13.1 - $16.35 $65,500 - $81,750	5,000 Added 13.81%	41,200 $603,000
Q2 2018 Aug 14, 2018	BUY	$13.65 - $18.7 $494,130 - $676,940	36,200 New	36,200 $525,000

541

68.3M

679K

423K

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $6.28B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

Get notified when there are updates to the investment portfolio of Meitav Dash Investments LTD, based on Form 13F filings with the SEC.

Stay updated on Meitav Dash Investments LTD with notifications on news.